Publications by authors named "Manabu Morimoto"

Claim this Profile
F
Feasibility of Novel Slim Peroral Cholangiopancreatoscopy for the Diagnosis of Pancreatobiliary Disease.
Haruo Miwa, Kazuya Sugimori, Kuniyasu Irie, Yoshihiro Goda, Kozue Shibasaki, Manabu Morimoto

DEN Open· April 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic ultrasound-guided tissue acquisition using a novel Franseen needle for ampullary gangliocytic paraganglioma.
Yuichi Suzuki, Haruo Miwa, Kazuki Endo, Ritsuko Oishi, Hiromi Tsuchiya, Manabu Morimoto

Endoscopy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Masatsugu Ohara, Goki Suda, Risako Kohya, Yutaka Yasui, Kaoru Tsuchiya, Manabu Morimoto

Hepatol Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-shaped bridging stenting for malignant hilar biliary obstruction with surgically altered anatomy.
Yuichi Suzuki, Haruo Miwa, Kazuki Endo, Ritsuko Oishi, Hiromi Tsuchiya, Manabu Morimoto

Endoscopy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parenchymal loop technique using a novel 0.018-inch guidewire in endoscopic ultrasound-guided pancreatic duct drainage.
Ritsuko Oishi, Haruo Miwa, Kazuki Endo, Hiromi Tsuchiya, Yuichi Suzuki, Manabu Morimoto

Endoscopy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness of tenofovir alafenamide versus entecavir in treatment-naïve chronic hepatitis B: A REAL-B study.
Jie Li, Joanne Kimiko Liu, Angela Chau, Sovann Linden, Pei-Chien Tsai, Manabu Morimoto

Am J Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Lenvatinib plus Pembrolizumab for Hepatocellular Carcinoma: Post hoc Analysis of Japanese Patients from the Phase 3 LEAP-002 Trial.
Masatoshi Kudo, Masafumi Ikeda, Hiroshi Aikata, Kazushi Numata, Hiroyuki Marusawa, Manabu Morimoto

Liver Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of carbon ion radiotherapy and transarterial chemoembolization for unresectable solitary hepatocellular carcinoma >3 cm: a propensity score-matched analysis.
Taito Fukushima, Satoshi Kobayashi, Hiroyuki Katoh, Tomomi Hamaguchi, Yuichiro Tozuka, Manabu Morimoto

J Radiat Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial.
George Lau, Bruno Sangro, Ann-Lii Cheng, Masatoshi Kudo, Robin Kate Kelley, Manabu Morimoto

Hepatology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of monotherapy and combination therapy for older patients with advanced biliary tract cancer: a retrospective study.
Ritsuko Oishi, Satoshi Kobayashi, Shuhei Nagashima, Taito Fukushima, Shun Tezuka, Manabu Morimoto

BMC Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of complete remission by cabozantinib as an end-line treatment for advanced hepatocellular carcinoma.
Shuhei Nagashima, Satoshi Kobayashi, Shotaro Tsunoda, Yui Yamachika, Yuichiro Tozuka, Manabu Morimoto

Clin J Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy of Detective Flow Imaging Endoscopic Ultrasonography for Evaluating Blood Flow Within Mural Nodules of Intraductal Papillary Mucinous Neoplasms.
Kazuki Endo, Haruo Miwa, Kazuya Sugimori, Kozue Shibasaki, Shoichiro Yonei, Manabu Morimoto

Diagnostics (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child-Pugh A category: A multicenter study.
Ying Zhang, Kazushi Numata, Kento Imajo, Haruki Uojima, Akihiro Funaoka, Manabu Morimoto

Hepatol Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steroid-Refractory Immune-Related Hepatitis Caused by Pembrolizumab with Stage IVB Non-Small Cell Lung Cancer: A Case Report.
Tomomi Hamaguchi, Makoto Ueno, Satoshi Kobayashi, Shun Tezuka, Manabu Morimoto

Case Rep Gastroenterol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma.
Makoto Chuma, Haruki Uojima, Hidenori Toyoda, Atsushi Hiraoka, Yoshitake Arase, Manabu Morimoto

Hepatol Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.
Satoshi Kobayashi, Taito Fukushima, Makoto Ueno, Makoto Chuma, Kazushi Numata, Manabu Morimoto

Liver Int· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD.
Masafumi Ikeda, Tatsuya Yamashita, Sadahisa Ogasawara, Masatoshi Kudo, Yoshitaka Inaba, Manabu Morimoto

Liver Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study.
Shuhei Nagashima, Satoshi Kobayashi, Shotaro Tsunoda, Yui Yamachika, Yuichiro Tozuka, Manabu Morimoto

Int J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapy.
Haruki Uojima, Makoto Chuma, Hisashi Hidaka, Takashi Tsuda, Satoshi Kobayashi, Manabu Morimoto

Eur J Gastroenterol Hepatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma who underwent curative resection.
Masaaki Murakawa, Shinnosuke Kawahara, Daishi Takahashi, Yuto Kamioka, Naoto Yamamoto, Manabu Morimoto

World J Surg Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Taito Fukushima, Manabu Morimoto, Satoshi Kobayashi, Makoto Ueno, Haruki Uojima

Oncologist· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Napabucasin Combined with Sorafenib in Japanese Patients with Unresectable Hepatocellular Carcinoma.
Takuji Okusaka, Manabu Morimoto, Yuichiro Eguchi, Shinichiro Nakamura, Shuichi Iino

Drugs R D· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.
Naoya Kato, Masatoshi Kudo, Kaoru Tsuchiya, Atsushi Hagihara, Kazushi Numata, Manabu Morimoto

Hepatol Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
Satoshi Kobayashi, Shun Tezuka, Yui Yamachika, Shotaro Tsunoda, Shuhei Nagashima, Manabu Morimoto

BMC Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel: A retrospective study.
Yuichiro Tozuka, Makoto Ueno, Satoshi Kobayashi, Manabu Morimoto, Taito Fukushima

Oncol Lett· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis